title: Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature.
abstract: Diabetic cardiomyopathy is associated with increased oxidative stress and vascular endothelial dysfunction, which lead to coronary microangiopathy. We tested whether statin-induced redox imbalance improvements could ameliorate diabetic cardiomyopathy and improve coronary microvasculature in streptozotocin-induced diabetes mellitus (DM). Fluvastatin (10 mg/kg/day) or vehicle was orally administered for 12 weeks to rats with or without DM. Myocardial oxidative stress was assessed by NADPH (nicotinamide adenine dinucleotide phosphate) oxidase subunit p22(phox) and gp91(phox) mRNA expression, and myocardial 8-iso-prostaglandin F(2α) (PGF(2α)) levels. Myocardial vascular densities were assessed using anti-CD31 and anti-α-smooth muscle actin (SMA) antibodies. Fluvastatin did not affect blood pressure or plasma cholesterol, but attenuated increased left ventricular (LV) minimum pressure and ameliorated LV systolic dysfunction in DM rats in comparison with vehicle (LV dP/dt, 8.9 ± 1.8 vs 5.4 ± 1.0 × 10(3) mmHg/s, P < 0.05). Myocardial oxidative stress increased in DM, but fluvastatin significantly reduced p22(phox) and gp91(phox) mRNA expression and myocardial PGF(2α) levels. Fluvastatin enhanced myocardial endothelial nitric oxide synthase (eNOS) protein levels and increased eNOS, vascular endothelial growth factor, and hypoxia-inducible factor-1α mRNA expression. CD31-positive cell densities were lower in DM rats than in non-DM rats (28.4 ± 13.2 vs 48.6 ± 4.3/field, P < 0.05) and fluvastatin restored the number (57.8 ± 18.3/field), although there were no significant differences in SMA-positive cell densities between groups. Fluvastatin did not affect cardiac function, oxidative stress, or vessel densities in non-DM rats. These results suggest that beneficial effects of fluvastatin on diabetic cardiomyopathy might result, at least in part, from improving coronary microvasculature through reduction in myocardial oxidative stress and upregulation of angiogenic factor.
authors: Second Department of Internal Medicine, Graduate School of Medicine, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
authors: Takuya
authors: T
authors: Shida
authors: Takashi
authors: T
authors: Nozawa
authors: Mitsuo
authors: M
authors: Sobajima
authors: Hiroyuki
authors: H
authors: Ihori
authors: Akira
authors: A
authors: Matsuki
authors: Hiroshi
authors: H
authors: Inoue
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D003331:Coronary Vessels / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D058065:Diabetic Cardiomyopathies / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D015232:Dinoprostone / Q000031:analogs & derivatives / Q000378:metabolism; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology*; D000077340:Fluvastatin; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism; D007211:Indoles / Q000494:pharmacology*; D028421:Isoprostanes / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism; D055806:Microvessels / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000235:genetics / Q000378:metabolism; D018919:Neovascularization, Physiologic / Q000187:drug effects; D052250:Nitric Oxide Synthase Type III / Q000235:genetics / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D017208:Rats, Wistar; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000378:metabolism; D016277:Ventricular Function, Left / Q000187:drug effects; D017725:Ventricular Pressure / Q000187:drug effects
chemical_list: D000199:Actins; D000975:Antioxidants; D015232:Dinoprostone; D005229:Fatty Acids, Monounsaturated; D000077340:Fluvastatin; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D007211:Indoles; D028421:Isoprostanes; D008562:Membrane Glycoproteins; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; D052250:Nitric Oxide Synthase Type III; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; C497444:Hif1a protein, rat; C498862:Acta2 protein, rat; C467498:vascular endothelial growth factor A, rat; C496316:Nos3 protein, rat; C500593:Cybb protein, rat; C515768:Cyba protein, rat; C011987:8-isoprostaglandin E2
references: Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1264-70
references: 16284235
references: Diabetes. 2007 Jul;56(7):1834-41
references: 17473225
references: Nature. 2000 Apr 13;404(6779):787-90
references: 10783895
references: Circulation. 2001 Mar 27;103(12):1618-23
references: 11273987
references: Circ Res. 2007 May 25;100(10):1415-27
references: 17525381
references: Circulation. 2002 Jan 22;105(3):373-9
references: 11804995
references: Acta Biochim Pol. 2003;50(1):49-59
references: 12673346
references: Circ J. 2006 Dec;70(12):1643-9
references: 17127814
references: Diabetes. 2002 Jun;51(6):1938-48
references: 12031984
references: J Clin Invest. 1999 Feb;103(3):421-7
references: 9927504
references: J Biol Chem. 1998 Sep 11;273(37):24266-71
references: 9727051
references: Circulation. 2002 Feb 19;105(7):868-73
references: 11854129
references: FASEB J. 1998 Dec;12(15):1777-83
references: 9837868
references: Biol Pharm Bull. 2000 Jul;23(7):873-8
references: 10919369
references: J Cardiovasc Pharmacol Ther. 2008 Mar;13(1):64-71
references: 18287592
references: Am J Physiol Heart Circ Physiol. 2001 Aug;281(2):H655-60
references: 11454569
references: Am J Cardiol. 2003 Feb 20;91(4A):14B-22B
references: 12615294
references: Circulation. 2005 Apr 26;111(16):2073-85
references: 15851615
references: Int J Cardiol. 2013 Oct 3;168(3):2474-80
references: 23590933
references: J Am Coll Cardiol. 1997 Nov 15;30(6):1472-7
references: 9362404
references: Hypertension. 2004 Jun;43(6):1214-20
references: 15166180
references: Nat Med. 2000 Sep;6(9):1004-10
references: 10973320
references: Eur J Pharmacol. 2012 Sep 5;690(1-3):31-41
references: 22705060
references: Diabetes. 2000 Nov;49(11):1939-45
references: 11078463
references: J Nucl Med. 2000 Jun;41(6):978-85
references: 10855621
references: Prog Cardiovasc Dis. 1985 Jan-Feb;27(4):255-70
references: 3880919
references: Heart Vessels. 2014 Jan;29(1):42-8
references: 23296264
references: Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H829-35
references: 19561313
references: Circulation. 2007 Jun 26;115(25):3213-23
references: 17592090
references: Diabetes. 2004 Jan;53(1):195-9
references: 14693715
references: Diabetes. 2003 Mar;52(3):777-83
references: 12606520
references: Microcirculation. 2000 Jun;7(3):163-81
references: 10901496
references: Diabetologia. 2005 Sep;48(9):1933-40
references: 16034613
references: Lancet. 2003 Jun 14;361(9374):2005-16
references: 12814710
references: J Clin Pathol. 2002 Aug;55(8):561-8
references: 12147646
references: Diabetologia. 2007 Sep;50(9):1977-1986
references: 17589825
references: Circ J. 2010 Mar;74(3):468-75
references: 20103973
references: Circ Res. 2006 Mar 17;98(5):596-605
references: 16543510
references: J Clin Invest. 2001 Aug;108(3):391-7
references: 11489932
references: Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1903-11
references: 10938010
references: Br J Pharmacol. 2007 Apr;150(7):873-82
references: 17351667
references: Clin Sci (Lond). 2009 May;116(10):741-60
references: 19364331
references: Diabetes Metab Rev. 1988 Aug;4(5):437-51
references: 2850143
references: J Appl Physiol (1985). 2005 Feb;98(2):461-7
references: 15465890
references: Brain. 2001 Dec;124(Pt 12):2448-58
references: 11701599
references: Circulation. 1999 Jan 19;99(2):224-9
references: 9892587
references: J Chromatogr B Biomed Sci Appl. 2000 Sep 1;746(1):17-24
references: 11048736
references: Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H548-54
references: 21622828
references: J Am Coll Cardiol. 2004 Dec 21;44(12):2368-74
references: 15607400
references: Chem Pharm Bull (Tokyo). 1999 Jul;47(7):1010-2
references: 10434403
references: Endocrinology. 2006 Dec;147(12):5967-74
references: 16935841
references: J Clin Invest. 2001 Nov;108(10):1429-37
references: 11714734
references: FEBS Lett. 2006 May 22;580(12):2879-87
references: 16631753